Examining the co-expression of FGF2 & PDGF-B revealed a HR of 6.0 for the high-high expression group (Table 2), indicating an additive or possibly a synergetic effect of these pathways in non-GIST STSs. This evidence concerns the gene PDGFB and gastrointestinal stromal tumor.